ERZEUGNISSE DER CHEMISCHEN INDUSTRIE UND VERWANDTER INDUSTRIEN > PHARMAZEUTISCHE ERZEUGNISSE > Watte, Gaze, Binden und ähnliche Erzeugnisse (z.|B. Verbandzeug, Pflaster zum Heilgebrauch, Senfpflaster), mit medikamentösen Stoffen getränkt oder überzogen oder in Aufmachungen für den Einzelverkauf zu medizinischen, chirurgischen, zahnärztlichen oder tierärztlichen Zwecken > Heftpflaster und andere Waren mit Klebeschicht
Warenproben
501. This chapter does not cover: (a) foods or beverages (such as dietetic, diabetic or fortified foods, food supplements, tonic beverages and mineral waters), other than nutritional preparations for intravenous administration (Section IV); (b) preparations such as tablets, chewing gum or patches which are intended to help smokers stop smoking (heading 2106 or 3824); (c) plasters specially calcined or finely ground for use in dentistry (heading 2520); (d) aqueous distillates or aqueous solutions of essential oils, suitable for medicinal uses (heading 3301); (e) preparations of headings 3303 to 3307, even if they have therapeutic or prophylactic properties; (f) soap or other products of heading 3401 containing added medicaments; (g) preparations with a basis of plaster for use in dentistry (heading 3407); (h) albumin not prepared for therapeutic or prophylactic uses (heading 3502). 2. For the purposes of heading 3002, 'immunological products' applies when such products are used directly on patients for therapeutic or prophylactic purposes, including monoclonal antibodies (MAbs), antibody fragments, antibody conjugates and antibody fragment conjugates. 3. For the purposes of headings 3003 and 3004, the following are to be treated as: (a) 'unmixed products': unmixed products dissolved in water; all goods of Chapters 28 or 29; and simple vegetable extracts of heading 1302, merely standardised or dissolved in any solvent; (b) 'mixed products': colloidal solutions and suspensions; mixtures obtained from extraction of vegetable substances or of animal substances; and products of Note 3(a) to which substances have been added. 4. Heading 3006 applies only to: sterile surgical catgut and similar sterile suture materials; sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental haemostatics; opacifying preparations for X-ray examinations and diagnostic reagents designed to be administered to the patient; blood-grouping reagents; dental cements and other dental fillings; bone reconstruction cements; first-aid boxes and kits; chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides; gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments; pharmaceutical waste.
1. (A) Products (other than radioactive ores) answering to a description in heading 2844 or 2845 are to be classified in those headings and in no other heading of the Nomenclature. (B) Subject to paragraph (A) above, products answering to a description in heading 2843, 2846 or 2852 are to be classified in those headings and in no other heading of this Section. 2. Subject to Note 1 above, products classifiable in heading 3004, 3005, 3006, 3212, 3303, 3304, 3305, 3306, 3307, 3506, 3707 or 3808 by reason of being put up in measured doses or for retail sale are to be classified in those headings and in no other heading of the Nomenclature. 3. Goods put up in sets consisting of two or more separate constituents, some or all of which fall in this Section and are intended to be mixed together to obtain a product of Section VI or VII, are to be classified in the heading appropriate to that product, provided that the constituents are: (a) having regard to the manner in which they are put up, clearly identifiable as being intended for use together without first being repacked; (b) presented together; and (c) identifiable, whether by their nature or by the relative proportions in which they are present, as being complementary one to another.
Quelle: Europäische Kommission - Erläuterungen zur KN (ENKN) und HS-Anmerkungen.
1214/91
Classification is determined by the provisions of General Rules 1 and 6 for the interpretation of the Combined Nomenclature and by the wording of CN codes 3005 and 3005 10 00 (see also the Explanatory Notes to the HS, heading 30.05, third paragraph). Documented CN 2026 code: 30051000.
3565/88
Classification is determined by the provisions of general rules 1 and 6 for the interpretation of te Combined Nomenclature and the wording of CN codes 3005 asnd 3005 10 00. Documented CN 2026 code: 30051000.
€0
€0
+€0
€18.47/kg
€39.78/kg
3.420
KonzentriertBeschaffungspartner in Drittländern
| # | Partner | Wert (EUR) | kg | €/kg | Anteil | Vj. |
|---|---|---|---|---|---|---|
| 1 | 🇨🇳 China | €1.1B | 95.6Mt | €11.81/kg | 50.8% | |
| 2 | 🇺🇸 United States | €473.2M | 12.3Mt | €38.53/kg | 21.3% | |
| 3 | 🇬🇧 United Kingdom | €410.3M | 6.9Mt | €59.84/kg | 18.5% | |
| 4 | 🇪🇬 Egypt | €106.8M | 8.3Mt | €12.79/kg | 4.8% | |
| 5 | 🇰🇷 South Korea | €103.0M | 2.0Mt | €51.90/kg | 4.6% |
Zielmärkte in Drittländern
| # | Partner | Wert (EUR) | kg | €/kg | Anteil | Vj. |
|---|---|---|---|---|---|---|
| 1 | 🇺🇸 United States | €1.1B | 25.0Mt | €44.78/kg | 51.3% | |
| 2 | 🇬🇧 United Kingdom | €483.4M | 14.7Mt | €32.78/kg | 22.2% | |
| 3 | 🇨🇭 Switzerland | €299.6M | 8.4Mt | €35.81/kg | 13.7% | |
| 4 | 🇯🇵 Japan | €149.6M | 2.9Mt | €51.90/kg | 6.9% | |
| 5 | 🇨🇳 China | €91.2M | 1.5Mt | €62.09/kg | 4.2% | |
| 6 | 🇸🇦 Saudi Arabia | €38.4M | 267Kt | €143.98/kg | 1.8% |